CD86 and hepatocellular carcinoma: For example, Han et al. analyzed circulating CD14 + , CD86 + dendritic cells from human hepatocellular carcinoma patients and found they express high levels of IL-10 and IDO and were capable of suppressing T-cell proliferation [62].